Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00343928 · ClinicalTrials.gov registry record · Phase 2
Amino Acids, Serotonin, and Body Weight Regulation
A Phase 2 study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 21
- Enrollment target
NCT00343928 is a Phase 2 study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 21 participants.
The verdict
NCT00343928, a Phase 2 study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 21 participants
- Enrollment target
Study Summary
This study will assess the behavioral effects of an amino acid mixture thought to influence serotonin function in individuals who have recovered from anorexia nervosa.
Interventions
- OTHER Branched-chain amino acids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2006-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00343928
The ClinicalTrials.gov registry entry for NCT00343928 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Branched-chain amino acids is the first listed.
NCT00343928 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00343928 about?
NCT00343928 is a clinical study titled "Amino Acids, Serotonin, and Body Weight Regulation". This study will assess the behavioral effects of an amino acid mixture thought to influence serotonin function in individuals who have recovered from anorexia nervosa.
What is the current status of trial NCT00343928?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 21 participants. The study started on 2006-06.
What interventions are being tested in trial NCT00343928?
The interventions under investigation include: Branched-chain amino acids (OTHER).
Who is sponsoring clinical trial NCT00343928?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.